Talia Cohen Solal is CEO and co-founder of Genetika+. Genetika+ is developing a personalized medical testing tool to better treat depression by helping physicians find the best drug therapy for their patients. The Genetika+ test uses innovative technology to predict the best drug treatment for each patient, enabling faster treatment, fewer side effects, and lower dosing.
Podcast key moments:
00:32 What motivates you to get out of bed in the morning and do what you do?
01:34 Can you tell us a little bit about how Genetika+ came to be?
02:39 Could you tell us a little bit more of your academic background
05:14 what was your first step into an “industry” role?
05:35 Tell us about your “Aliyah” and what perpetuated the move from Minneapolis to Israel
06:50 What does Genetika+ do?
08:10 Did you say brain-in-a-dish?
08:30 Why did you decide to focus on precision medicine for a small group of patients instead of searching for a treatment that would be relevant to a larger group?
10:40 So, where do you see Genetika+ fitting in the patient's continuum of care?
12:20 What do you think are your major challenges now to be able to get to the patients who need your product?
14:30 What does it mean to you being an entrepreneur? Were you born that way? Or is it something that was sparked a little bit later on in your journey?
16:00 Do you have any advice for any child, woman or man who is interested in going the route that you've gone? What's your support network like?
18:`5 What is the value you take from accelerator programs and competitions? Why would you recommend that to a startup?
23:45 Can you give us a little bit on your perspective on you know, why it is that they're less female CEOs in our space, in the health technology space?
28:00 What are your plans going forward and when will you begin Clinical Trials?
Talia Cohen Solal is CEO and co-founder of Genetika+. Genetika+ is developing a personalized medical testing tool to better treat depression by helping physicians find the best drug therapy for their patients. The Genetika+ test uses innovative technology to predict the best drug treatment for each patient, enabling faster treatment, fewer side effects, and lower dosing.
Podcast key moments:
00:32 What motivates you to get out of bed in the morning and do what you do?
01:34 Can you tell us a little bit about how Genetika+ came to be?
02:39 Could you tell us a little bit more of your academic background
05:14 what was your first step into an “industry” role?
05:35 Tell us about your “Aliyah” and what perpetuated the move from Minneapolis to Israel
06:50 What does Genetika+ do?
08:10 Did you say brain-in-a-dish?
08:30 Why did you decide to focus on precision medicine for a small group of patients instead of searching for a treatment that would be relevant to a larger group?
10:40 So, where do you see Genetika+ fitting in the patient's continuum of care?
12:20 What do you think are your major challenges now to be able to get to the patients who need your product?
14:30 What does it mean to you being an entrepreneur? Were you born that way? Or is it something that was sparked a little bit later on in your journey?
16:00 Do you have any advice for any child, woman or man who is interested in going the route that you've gone? What's your support network like?
18:`5 What is the value you take from accelerator programs and competitions? Why would you recommend that to a startup?
23:45 Can you give us a little bit on your perspective on you know, why it is that they're less female CEOs in our space, in the health technology space?
28:00 What are your plans going forward and when will you begin Clinical Trials?